Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2016 Jun 21;57(1):7–32. doi: 10.1002/jcph.766

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2016, The Authors. The Journal of Clinical Pharmacology Published by Wiley Periodicals, Inc. on behalf of American College of Clinical Pharmacology

This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial‐NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.

PMC Copyright notice

Overview of the ODYSSEY program for efficacy and safety of alirocumab (phase 2 and phase 3 clinical trials).52, 54, 58, 59, 65, 66, 67, 68, 73, 74, 76, 77, 78 Gray shading represents ongoing or planned studies. CV, cardiovascular; HeFH, heterozygous familial hypercholesterolemia; LDL‐C, low‐density lipoprotein cholesterol; SI, statin intolerance. ^aPatients with type 1 or type 2 diabetes who are treated with insulin. ^bEstimated enrollment. ^cJapanese population. ^dPatients with type 2 diabetes and mixed dyslipidemia.